The uptick in the Morepen Labs share came after the company announced that it has rolled out ‘Empamore.’ Empamore is used to ...

Haryana: Morepen Labs has announced that the Ministry of Corporate Affairs has approved the incorporation of 'QUICK MED ...

Morepen Labs has executed a Business Transfer Agreement (BTA) with Morepen Medtech for the transfer of its medical devices ...

Morepen Laboratories Limited announces the launch of Empamore, a game-changing treatment for Type 2 Diabetes Mellitus, Heart ...

Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Pharmaceutical company Morepen Laboratories Ltd on Monday (March 17) said it has launched a new treatment for Type 2 diabetes, heart failure, and chronic kidney disease. The drug, Empamore, is said to ...

Morepen Laboratories surged 8.90% to Rs 46.61 after the company launched Empamore, an affordable treatment for type 2 diabetes, heart failure, and chronic kidney disease in India.

On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...

The NSE Nifty 50 ended 1.45% higher at 22,834.30, while the BSE Sensex closed 1.53% up at 75,301.26 on Tuesday.

Experts recommend four stocks to buy or sell on Friday — Imagicaaworld Entertainment, Dhani Services, SJVN, and Morepen ...

Equity markets surge on positive global cues, banking stocks lead gains, Sensex closes at 75,301.26, Nifty at 22,834.30.

Morepen Laboratories Ltd share price was down by -0.55% from the previous closing price of ₹45.08. Who are peers of Morepen Laboratories Ltd? The peers of Morepen Laboratories Ltd are Sun ...